TransMedics (TMDX) director gifts 18,000 shares
Rhea-AI Filing Summary
TransMedics Group, Inc. director James R. Tobin reported a bona fide gift transfer of 18,000 shares of common stock on 2026-08-17 from an indirect holding titled "The Tobin 2024 Family Trust," leaving that trust with 0 shares. Following this reporting, Tobin holds 6,981 shares of TransMedics common stock directly and 155,146 shares indirectly through the "James R. Tobin 2012 Trust."
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 18,000 shares
Net Sell
3 txns
Insider
TOBIN JAMES R
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 18,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 0 shares (Indirect, By The Tobin 2024 Family Trust);
Common Stock — 6,981 shares (Direct);
Common Stock — 155,146 shares (Indirect, By the James R. Tobin 2012 Trust)
Key Figures
Shares transferred by gift: 18,000 shares
Shares remaining in The Tobin 2024 Family Trust: 0 shares
Direct holdings after transaction: 6,981 shares
+2 more
5 metrics
Shares transferred by gift
18,000 shares
Bona fide gift of common stock from The Tobin 2024 Family Trust on 2026-08-17
Shares remaining in The Tobin 2024 Family Trust
0 shares
Total shares following the 18,000-share gift transaction
Direct holdings after transaction
6,981 shares
Common stock directly held by James R. Tobin following the reported transactions
Indirect holdings via 2012 Trust
155,146 shares
Common stock held indirectly by the James R. Tobin 2012 Trust following the reported transactions
Reported gift price per share
$0.0000 per share
Price field for the 18,000-share bona fide gift transaction
Key Terms
bona fide gift, indirect ownership, Form 4
3 terms
bona fide gift financial
"The transaction is reported with the code G as a bona fide gift"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
indirect ownership financial
"The shares were held in indirect ownership by The Tobin 2024 Family Trust"
Form 4 regulatory
"The insider reported these changes in a Form 4 ownership filing"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What did TransMedics Group (TMDX) director James R. Tobin report on this Form 4?
James R. Tobin reported a bona fide gift of 18,000 shares of TransMedics common stock from an indirect trust holding. The filing also updates his remaining direct and indirect shareholdings after this gift transfer.
What are James R. Tobin’s direct holdings in TransMedics (TMDX) after the reported transactions?
After the reported transactions, James R. Tobin directly holds 6,981 shares of TransMedics common stock. This direct position is separate from his indirect holdings through family trusts disclosed in the same Form 4.
What indirect TransMedics (TMDX) holdings does James R. Tobin report after this Form 4?
Following the gift, Tobin reports 155,146 shares of TransMedics common stock held indirectly by the "James R. Tobin 2012 Trust." The previously reported "Tobin 2024 Family Trust" shows 0 shares remaining after the 18,000-share gift.
AI-generated analysis. How Rhea-AI works. Not financial advice.
